Total Payments
$1.3M
2024 Payments
$362,806
Companies
17
Transactions
1,428
Medicare Patients
665
Medicare Billing
$80,504
Payment Breakdown by Category
Other$922,480 (71.7%)
Consulting$182,689 (14.2%)
Travel$140,117 (10.9%)
Food & Beverage$35,406 (2.8%)
Education$5,694 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $520,355 | 215 | 40.5% |
| Honoraria | $393,125 | 140 | 30.6% |
| Consulting Fee | $182,689 | 121 | 14.2% |
| Travel and Lodging | $140,117 | 492 | 10.9% |
| Food and Beverage | $35,406 | 449 | 2.8% |
| Grant | $9,000 | 2 | 0.7% |
| Education | $5,694 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $483,744 | 435 | $0 (2024) |
| Neurelis, Inc. | $305,934 | 352 | $0 (2024) |
| LivaNova USA, Inc. | $246,453 | 285 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $109,482 | 100 | $0 (2024) |
| NEUROPACE, INC. | $105,571 | 185 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $16,172 | 31 | $0 (2021) |
| UCB, Inc. | $13,677 | 25 | $0 (2023) |
| Eisai Inc. | $3,360 | 1 | $0 (2020) |
| Antares Pharma, Inc. | $600.00 | 1 | $0 (2020) |
| Horizon Therapeutics plc | $493.49 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $362,806 | 374 | SK Life Science, Inc. ($130,932) |
| 2023 | $301,823 | 362 | Neurelis, Inc. ($103,434) |
| 2022 | $303,743 | 311 | SK Life Science, Inc. ($111,553) |
| 2021 | $164,575 | 169 | SK Life Science, Inc. ($78,400) |
| 2020 | $100,511 | 98 | SK Life Science, Inc. ($74,209) |
| 2019 | $15,241 | 30 | NeuroPace, Inc. ($9,910) |
| 2018 | $13,239 | 31 | NEUROPACE, INC. ($13,114) |
| 2017 | $24,448 | 53 | NEUROPACE, INC. ($24,227) |
All Payment Transactions
1,428 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,077.50 | General |
| Category: Neurology | ||||||
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $89.46 | General |
| Category: Neurology | ||||||
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: Neurology | ||||||
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $25.65 | General |
| Category: Neurology | ||||||
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $11.50 | General |
| Category: Neurology | ||||||
| 12/27/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $9,100.00 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $1,400.00 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $312.79 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $78.00 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $24.12 | General |
| Category: Neurology | ||||||
| 12/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | Cash or cash equivalent | $8.73 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $2,142.00 | General |
| Category: EPILEPSY | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,170.00 | General |
| Category: Neurology | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $277.20 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $47.57 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $47.57 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $31.24 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $11.50 | General |
| Category: EPILEPSY | ||||||
| 12/10/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,170.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,780.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $205.38 | General |
| Category: Neurology | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 92 | 110 | $51,812 | $12,325 |
| 2022 | 6 | 191 | 205 | $58,673 | $20,414 |
| 2021 | 5 | 155 | 178 | $49,652 | $18,875 |
| 2020 | 6 | 227 | 258 | $113,661 | $28,889 |
Total Patients
665
Total Services
751
Medicare Billing
$80,504
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 33 | 49 | $34,636 | $7,558 | 21.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 18 | 18 | $6,656 | $1,820 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $3,956 | $1,194 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $2,856 | $1,122 | 39.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 12 | 12 | $3,708 | $630.69 | 17.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 24 | 34 | $11,968 | $5,479 | 45.8% |
| 95723 | Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | Facility | 2022 | 19 | 19 | $8,322 | $3,584 | 43.1% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2022 | 43 | 43 | $13,287 | $2,759 | 20.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 24 | 25 | $5,700 | $2,571 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 26 | $6,032 | $2,358 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $3,473 | $1,318 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $2,784 | $1,219 | 43.8% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 23 | 23 | $7,107 | $1,126 | 15.8% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 28 | 48 | $16,896 | $7,845 | 46.4% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 33 | 33 | $7,524 | $3,516 | 46.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 21 | $4,872 | $2,221 | 45.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 16 | 18 | $4,176 | $1,895 | 45.4% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2021 | 30 | 30 | $9,270 | $1,620 | 17.5% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Office | 2021 | 17 | 17 | $5,253 | $1,064 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $1,661 | $714.78 | 43.0% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 67 | 96 | $62,272 | $17,069 | 27.4% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 45 | 47 | $18,132 | $5,335 | 29.4% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 45 | 45 | $8,205 | $1,907 | 23.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 18 | $4,613 | $1,590 | 34.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 16 | 16 | $3,592 | $1,330 | 37.0% |
About Dr. Danielle Becker, MD
Dr. Danielle Becker, MD is a Neurology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134381759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Becker, MD has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $362,806 received in 2024. These payments were reported across 1,428 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($520,355).
As a Medicare-enrolled provider, Becker has provided services to 665 Medicare beneficiaries, totaling 751 services with total Medicare billing of $80,504. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Epilepsy
- Location Columbus, OH
- Active Since 06/25/2008
- Last Updated 08/23/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1134381759
Products in Payments
- XCOPRI (Drug) $415,035
- VALTOCO (Drug) $300,753
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $161,122
- EPIDIOLEX (Drug) $107,982
- Cenobamate (Drug) $67,982
- RNS System (Device) $61,960
- VNS Therapy SenTiva Model 1000 Generator (Device) $46,658
- RNS Neurostimulator Kit (Device) $43,611
- VNS Therapy (Device) $24,940
- OXTELLAR XR (Drug) $16,172
- VNS - Sentiva (Device) $13,692
- Briviact (Drug) $9,202
- Fintepla (Drug) $4,222
- Fycompa (Drug) $3,360
- XYOSTED (Drug) $600.00
- UPLIZNA (Drug) $493.49
- Epidiolex (Drug) $293.10
- GILENYA (Drug) $125.00
- SABRIL (Drug) $125.00
- ACTIVA (Device) $36.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Columbus
Kenneth Mankowski, Do, DO
Neurology — Payments: $1.9M
Neurology $1.9M
Dr. Aaron Boster, Md, MD
Neurology — Payments: $1.9M
Neurology $1.9M
Dr. Jacqueline Nicholas, M.d, M.D
Neurology — Payments: $967,203
Neurology $967,203
Dr. Jonathan Liss, M.d, M.D
Neurology — Payments: $468,143
Neurology $468,143
Jerry Mendell, Md, MD
Neurology — Payments: $371,804
Neurology $371,804
Dr. Andrew Smith, M.d, M.D
Neurology — Payments: $277,150
Neurology $277,150